Chronic myelogenous leukemia after treatment with 131I for thyroid carcinoma
- 1 September 1991
- journal article
- case report
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 55 (2) , 217-224
- https://doi.org/10.1016/0165-4608(91)90080-e
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Philadelphia chromosome-positive chronic myelogenous leukemia in treated Hodgkin's diseaseCancer Genetics and Cytogenetics, 1990
- The site of the breakpoint within the bcr is a prognostic factor in Philadelphia-positive CML patients [see comments]Blood, 1988
- Solid cancer risk after treatment of Hodgkin's diseaseCancer, 1988
- The long-term hazards of the treatment of thyroid cancer with radioiodineThe British Journal of Radiology, 1986
- A technique for radiolabeling DNA restriction endonuclease fragments to high specific activityAnalytical Biochemistry, 1984
- Late side effects of chemotherapy in ovarian carcinoma: A cytogenetic, hematologic, and statistical studyCancer, 1982
- Acute non-lymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with treosulfan (=dihydroxybusulfan)Cancer, 1980
- Acute leukemia after chemotherapy (melphalan)Cancer, 1978
- Chronic myelogenous leukemia in Hodgkin's disease: Immunofluorescence of cellsCancer, 1971
- Incidence of Leukemia Following Treatment of HyperthyroidismPublished by American Medical Association (AMA) ,1968